We demonstrated that Dox treatment activated MG53 and improved engraftment of HiPSC-CMs in infarct hearts, resulting in the reduction of fibrotic remodeling and restoration of heart function after MI via activation of the AKT signaling pathway. This evidence concerns the gene AKT1 and myocardial infarction.